Bryan Giraudo

Mr. Giraudo has recently joined us as a member of our board of directors. He has served as Chief Financial Officer of Gossamer Bio since May 2018. From August 2009 to May 2018, Mr. Giraudo served as Senior Managing Director at Leerink Partners, where he was responsible for Leerink’s Western North America and Asia life sciences investment banking practice. While at Leerink, he executed more than 150 initial public offerings, follow-on, convertible and structured debt and equity transactions, as well as product and company buy-side, sell-side and corporate collaboration strategic advisory assignments for biotechnology and pharmaceutical clients. From July 1997 to July 2009, Mr. Giraudo was a Managing Director in Merrill Lynch’s Global Healthcare Investment Banking Group. Mr. Giraudo received his B.A. from Georgetown University.